Corporate Board Profile
Tech Score: 0/100
Filing Date | Source Excerpt |
---|---|
2016-03-28 | Ms. Lewent served as Chief Financial Officer of Merck, a pharmaceutical company, from 1990 until her retirement in 2007. Board Committees: Audit (Chair), Executive. 2015 total compensation for Ms. Lewent was $260,019. |
2017-03-27 | Ms. Lewent served as CFO of Merck. Board Committees: Audit (Chair), Executive. 2016 director compensation total $260,031. |
2018-03-28 | Ms. Lewent served as Chief Financial Officer of Merck. Board Committees: Audit (Chair), Executive. 2017 director compensation total $312,583. |
2019-03-28 | Ms. Lewent served as Chief Financial Officer of Merck, a pharmaceutical company, from 1990 until her retirement in 2007. Board Committees: Audit (Chair), Executive Director Qualifications: Independent Age: 70 Director since: 2011 |
2020-03-27 | Ms. Lewent served as Chief Financial Officer of Merck. Board Committees: Audit (Chair), Executive. Fees Earned or Paid in Cash: 125,000, Stock Awards: 190,066, Total: 315,066 |
2021-04-01 | Ms. Lewent served as CFO of Merck. Board Committees: Audit (Chair), Executive. 2020 compensation total $301,271. |
2022-03-31 | Ms. Lewent served as Chief Financial Officer of Merck. Board Committees: Audit (Chair), Executive. Total compensation: $315,184. |
2023-03-30 | Ms. Lewent served as Chief Financial Officer of Merck. Board Committees: Audit (Chair), Executive. Compensation: $345,162 |
2024-03-28 | Ms. Lewent served as Chief Financial Officer of Merck, a pharmaceutical company, from 1990 until her retirement in 2007. Board Committees: Audit (Chair), Executive Director Qualifications: Public company CFO, financial and accounting expertise, capital allocation, global business, and human capital management experience as the former CFO of Merck Principal Occupation: Retired; Formerly Executive Vice President & Chief Financial Officer, Merck & Co., Inc. Age: 75 Race: White Director since: 2011 Independent |
Filing Date | Source Excerpt |
---|---|
2018-04-10 | Ms. Lewent, age 69, has been a director of the Company since May 2008. She was Chief Financial Officer of Merck & Co., Inc. |
2019-04-09 | Former Chief Financial Officer, Merck & Co., Inc. |
2020-04-07 | Ms. Lewent’s nearly 20 years in executive management roles at Merck & Co., Inc. enables her to bring valuable experience in a highly regulated industry. |
Data sourced from SEC filings. Last updated: 2025-07-01